ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE

The present invention is directed to aryl sulfamide derivatives of formula (I): or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, which are monoamine reuptake inhibitors, compositions containing these derivatives, and methods of their use for the prevention and treatment of co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CASEY CAMERON MC COMAS, JOEL ADAM GOLDBERG, PUWEN ZHANG, RICHARD PAGE WOODWORTH, JR, JOSEPH P. SABATUCCI, PAIGE ERIN MAHANEY, EUGENE ANTHONY TEREFENKO, ANDREW FENSOME, CHARLES WILLIAM MANN, DOUGLAS JOHN JENKINS, EUGENE JOHN TRYBULSKI, MATTHEW L. CRAWLEY, MICHAEL ANTHONY MARELLA, STEPHEN TODD COHN, AN THIEN VU, CALLAIN YOUNGHEE KIM, DAVID JOHN O'NEILL
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CASEY CAMERON MC COMAS
JOEL ADAM GOLDBERG
PUWEN ZHANG
RICHARD PAGE WOODWORTH, JR
JOSEPH P. SABATUCCI
PAIGE ERIN MAHANEY
EUGENE ANTHONY TEREFENKO
ANDREW FENSOME
CHARLES WILLIAM MANN
DOUGLAS JOHN JENKINS
EUGENE JOHN TRYBULSKI
MATTHEW L. CRAWLEY
MICHAEL ANTHONY MARELLA
STEPHEN TODD COHN
AN THIEN VU
CALLAIN YOUNGHEE KIM
DAVID JOHN O'NEILL
description The present invention is directed to aryl sulfamide derivatives of formula (I): or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, which are monoamine reuptake inhibitors, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions, including, inter alia, vasomotor symptoms, sexual dysfunction, gastrointestinal disorders and genitourinary disorder, depression disorders, endogenous behavioral disorders, cognitive disorders, diabetic neuropathy, pain, and other diseases or disorders. La presente invención se dirige a derivados de ant sulfamida de la fórmula 1: (ver fórmula (I)) una sal farmacéuticamente aceptable, estereoisómero o tautómero de estos, que son inhibidores de recaptación de monoamina, composiciones que contienen estos derivados, y métodos para su uso para la prevención y tratamiento de afecciones, que incluyen, ínter alia, síntomas vasomotrices, disfunción sexual, trastornos gastrointestinales y trastorno genitourinario, trastornos depresivos, trastornos de comportamiento endogéno, trastornos cognitivos, neuropatía diabética, dolor, y otros enfermedades y trastornos.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2009006359A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2009006359A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2009006359A3</originalsourceid><addsrcrecordid>eNrjZDB2DIr0UQgO9XFz9PV0cVVwcQ3yDHMM8QxzDVZw9HNR8HUN8fB3CVbwd1MI8XD1DFIIDXblYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBgaWBgZmxqaWjsZEKQIA5PgnhQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE</title><source>esp@cenet</source><creator>CASEY CAMERON MC COMAS ; JOEL ADAM GOLDBERG ; PUWEN ZHANG ; RICHARD PAGE WOODWORTH, JR ; JOSEPH P. SABATUCCI ; PAIGE ERIN MAHANEY ; EUGENE ANTHONY TEREFENKO ; ANDREW FENSOME ; CHARLES WILLIAM MANN ; DOUGLAS JOHN JENKINS ; EUGENE JOHN TRYBULSKI ; MATTHEW L. CRAWLEY ; MICHAEL ANTHONY MARELLA ; STEPHEN TODD COHN ; AN THIEN VU ; CALLAIN YOUNGHEE KIM ; DAVID JOHN O'NEILL</creator><creatorcontrib>CASEY CAMERON MC COMAS ; JOEL ADAM GOLDBERG ; PUWEN ZHANG ; RICHARD PAGE WOODWORTH, JR ; JOSEPH P. SABATUCCI ; PAIGE ERIN MAHANEY ; EUGENE ANTHONY TEREFENKO ; ANDREW FENSOME ; CHARLES WILLIAM MANN ; DOUGLAS JOHN JENKINS ; EUGENE JOHN TRYBULSKI ; MATTHEW L. CRAWLEY ; MICHAEL ANTHONY MARELLA ; STEPHEN TODD COHN ; AN THIEN VU ; CALLAIN YOUNGHEE KIM ; DAVID JOHN O'NEILL</creatorcontrib><description>The present invention is directed to aryl sulfamide derivatives of formula (I): or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, which are monoamine reuptake inhibitors, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions, including, inter alia, vasomotor symptoms, sexual dysfunction, gastrointestinal disorders and genitourinary disorder, depression disorders, endogenous behavioral disorders, cognitive disorders, diabetic neuropathy, pain, and other diseases or disorders. La presente invención se dirige a derivados de ant sulfamida de la fórmula 1: (ver fórmula (I)) una sal farmacéuticamente aceptable, estereoisómero o tautómero de estos, que son inhibidores de recaptación de monoamina, composiciones que contienen estos derivados, y métodos para su uso para la prevención y tratamiento de afecciones, que incluyen, ínter alia, síntomas vasomotrices, disfunción sexual, trastornos gastrointestinales y trastorno genitourinario, trastornos depresivos, trastornos de comportamiento endogéno, trastornos cognitivos, neuropatía diabética, dolor, y otros enfermedades y trastornos.</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090626&amp;DB=EPODOC&amp;CC=MX&amp;NR=2009006359A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090626&amp;DB=EPODOC&amp;CC=MX&amp;NR=2009006359A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CASEY CAMERON MC COMAS</creatorcontrib><creatorcontrib>JOEL ADAM GOLDBERG</creatorcontrib><creatorcontrib>PUWEN ZHANG</creatorcontrib><creatorcontrib>RICHARD PAGE WOODWORTH, JR</creatorcontrib><creatorcontrib>JOSEPH P. SABATUCCI</creatorcontrib><creatorcontrib>PAIGE ERIN MAHANEY</creatorcontrib><creatorcontrib>EUGENE ANTHONY TEREFENKO</creatorcontrib><creatorcontrib>ANDREW FENSOME</creatorcontrib><creatorcontrib>CHARLES WILLIAM MANN</creatorcontrib><creatorcontrib>DOUGLAS JOHN JENKINS</creatorcontrib><creatorcontrib>EUGENE JOHN TRYBULSKI</creatorcontrib><creatorcontrib>MATTHEW L. CRAWLEY</creatorcontrib><creatorcontrib>MICHAEL ANTHONY MARELLA</creatorcontrib><creatorcontrib>STEPHEN TODD COHN</creatorcontrib><creatorcontrib>AN THIEN VU</creatorcontrib><creatorcontrib>CALLAIN YOUNGHEE KIM</creatorcontrib><creatorcontrib>DAVID JOHN O'NEILL</creatorcontrib><title>ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE</title><description>The present invention is directed to aryl sulfamide derivatives of formula (I): or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, which are monoamine reuptake inhibitors, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions, including, inter alia, vasomotor symptoms, sexual dysfunction, gastrointestinal disorders and genitourinary disorder, depression disorders, endogenous behavioral disorders, cognitive disorders, diabetic neuropathy, pain, and other diseases or disorders. La presente invención se dirige a derivados de ant sulfamida de la fórmula 1: (ver fórmula (I)) una sal farmacéuticamente aceptable, estereoisómero o tautómero de estos, que son inhibidores de recaptación de monoamina, composiciones que contienen estos derivados, y métodos para su uso para la prevención y tratamiento de afecciones, que incluyen, ínter alia, síntomas vasomotrices, disfunción sexual, trastornos gastrointestinales y trastorno genitourinario, trastornos depresivos, trastornos de comportamiento endogéno, trastornos cognitivos, neuropatía diabética, dolor, y otros enfermedades y trastornos.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB2DIr0UQgO9XFz9PV0cVVwcQ3yDHMM8QxzDVZw9HNR8HUN8fB3CVbwd1MI8XD1DFIIDXblYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBgaWBgZmxqaWjsZEKQIA5PgnhQ</recordid><startdate>20090626</startdate><enddate>20090626</enddate><creator>CASEY CAMERON MC COMAS</creator><creator>JOEL ADAM GOLDBERG</creator><creator>PUWEN ZHANG</creator><creator>RICHARD PAGE WOODWORTH, JR</creator><creator>JOSEPH P. SABATUCCI</creator><creator>PAIGE ERIN MAHANEY</creator><creator>EUGENE ANTHONY TEREFENKO</creator><creator>ANDREW FENSOME</creator><creator>CHARLES WILLIAM MANN</creator><creator>DOUGLAS JOHN JENKINS</creator><creator>EUGENE JOHN TRYBULSKI</creator><creator>MATTHEW L. CRAWLEY</creator><creator>MICHAEL ANTHONY MARELLA</creator><creator>STEPHEN TODD COHN</creator><creator>AN THIEN VU</creator><creator>CALLAIN YOUNGHEE KIM</creator><creator>DAVID JOHN O'NEILL</creator><scope>EVB</scope></search><sort><creationdate>20090626</creationdate><title>ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE</title><author>CASEY CAMERON MC COMAS ; JOEL ADAM GOLDBERG ; PUWEN ZHANG ; RICHARD PAGE WOODWORTH, JR ; JOSEPH P. SABATUCCI ; PAIGE ERIN MAHANEY ; EUGENE ANTHONY TEREFENKO ; ANDREW FENSOME ; CHARLES WILLIAM MANN ; DOUGLAS JOHN JENKINS ; EUGENE JOHN TRYBULSKI ; MATTHEW L. CRAWLEY ; MICHAEL ANTHONY MARELLA ; STEPHEN TODD COHN ; AN THIEN VU ; CALLAIN YOUNGHEE KIM ; DAVID JOHN O'NEILL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2009006359A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>CASEY CAMERON MC COMAS</creatorcontrib><creatorcontrib>JOEL ADAM GOLDBERG</creatorcontrib><creatorcontrib>PUWEN ZHANG</creatorcontrib><creatorcontrib>RICHARD PAGE WOODWORTH, JR</creatorcontrib><creatorcontrib>JOSEPH P. SABATUCCI</creatorcontrib><creatorcontrib>PAIGE ERIN MAHANEY</creatorcontrib><creatorcontrib>EUGENE ANTHONY TEREFENKO</creatorcontrib><creatorcontrib>ANDREW FENSOME</creatorcontrib><creatorcontrib>CHARLES WILLIAM MANN</creatorcontrib><creatorcontrib>DOUGLAS JOHN JENKINS</creatorcontrib><creatorcontrib>EUGENE JOHN TRYBULSKI</creatorcontrib><creatorcontrib>MATTHEW L. CRAWLEY</creatorcontrib><creatorcontrib>MICHAEL ANTHONY MARELLA</creatorcontrib><creatorcontrib>STEPHEN TODD COHN</creatorcontrib><creatorcontrib>AN THIEN VU</creatorcontrib><creatorcontrib>CALLAIN YOUNGHEE KIM</creatorcontrib><creatorcontrib>DAVID JOHN O'NEILL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CASEY CAMERON MC COMAS</au><au>JOEL ADAM GOLDBERG</au><au>PUWEN ZHANG</au><au>RICHARD PAGE WOODWORTH, JR</au><au>JOSEPH P. SABATUCCI</au><au>PAIGE ERIN MAHANEY</au><au>EUGENE ANTHONY TEREFENKO</au><au>ANDREW FENSOME</au><au>CHARLES WILLIAM MANN</au><au>DOUGLAS JOHN JENKINS</au><au>EUGENE JOHN TRYBULSKI</au><au>MATTHEW L. CRAWLEY</au><au>MICHAEL ANTHONY MARELLA</au><au>STEPHEN TODD COHN</au><au>AN THIEN VU</au><au>CALLAIN YOUNGHEE KIM</au><au>DAVID JOHN O'NEILL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE</title><date>2009-06-26</date><risdate>2009</risdate><abstract>The present invention is directed to aryl sulfamide derivatives of formula (I): or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, which are monoamine reuptake inhibitors, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions, including, inter alia, vasomotor symptoms, sexual dysfunction, gastrointestinal disorders and genitourinary disorder, depression disorders, endogenous behavioral disorders, cognitive disorders, diabetic neuropathy, pain, and other diseases or disorders. La presente invención se dirige a derivados de ant sulfamida de la fórmula 1: (ver fórmula (I)) una sal farmacéuticamente aceptable, estereoisómero o tautómero de estos, que son inhibidores de recaptación de monoamina, composiciones que contienen estos derivados, y métodos para su uso para la prevención y tratamiento de afecciones, que incluyen, ínter alia, síntomas vasomotrices, disfunción sexual, trastornos gastrointestinales y trastorno genitourinario, trastornos depresivos, trastornos de comportamiento endogéno, trastornos cognitivos, neuropatía diabética, dolor, y otros enfermedades y trastornos.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX2009006359A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T20%3A29%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CASEY%20CAMERON%20MC%20COMAS&rft.date=2009-06-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2009006359A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true